Wall Street lowered price targets on SHOP from every direction Wednesday. The stock fell 17% on its May 5 earnings print. Analysts are still largely bullish — but the numbers tell a more cautious story.
Eight analysts cut their price targets on May 6 alone. No firm downgraded its rating. But the magnitude of some cuts was notable.
DA Davidson dropped its target from $195 to $140 — a $55 reduction. Wells Fargo cut from $166 to $144. Canaccord Genuity moved from $165 to $145. Barclays trimmed to $126 from $130.
RBC Capital and Needham held firm. RBC reiterated Outperform at $170. Needham kept its Buy and $180 target unchanged.
The consensus target now sits at $153.42. The stock closed at $105.44 on May 6. That implies roughly 45% upside to the mean — on paper, a wide gap. In practice, it reflects targets that haven't fully reset after the post-earnings drop.
The put/call ratio jumped to 0.85 on May 6. That's a z-score of 3.17 — well above the 20-day mean of 0.71. The 52-week range runs from 0.58 to 1.10.
Hedging demand rose sharply after the earnings miss. The PCR had been tracking near its 20-day average for most of April. The spike on May 6 stands out clearly against that flat baseline.
Short interest sits at 1.57% of free float — modest by any standard. The borrow market reflects that. Cost to borrow is 0.54% as of May 5, down from a brief spike to 1.24% on May 1.
Availability remains loose. There is no sign of a crowded short trade. The lending data does not corroborate a squeeze setup.
The ORTEX short score is 29.2 — well below levels that would signal elevated short pressure.
The bull case centres on Shopify's international expansion, pricing power in subscriptions, and a large addressable market. The bear case flags tariff exposure, De Minimis rule changes, and SMB merchant churn risk in a weaker economy.
Founder and CEO Tobias Lütke sold 72,000 shares on April 29 for roughly $8.7 million. President Harley Finkelstein sold smaller amounts around the same period. The trades carry low significance scores and appear routine — but the timing, just before the earnings drop, is worth noting.
What to watch: Whether analyst targets continue to reset lower in the coming weeks, and whether the options PCR normalises or holds elevated.
See the live data behind this article on ORTEX.
Open SHOP on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
